Comparative analysis of clinical symptoms and biochemical alterations in women with polycystic ovary syndrome: assessing the impact of type 1 diabetes versus non-diabetic controls

Middle East Fertility Society Journal

Table 2 Anthropometric measurements of the study population

Anthropometric parameter	Non-diabetic controls (No. = 50)	Diabetic patients (No. = 50)	Test		P-value
BMI
Mean ± SD	25.1 ± 4.9	26.1 ± 4.5	T	0.973	0.333
Range (min–max)	16–37	18–36
Waist-to-hip ratio
Mean ± SD)	78.8 ± 5.7	81.9 ± 7.9	T	2.033	0.045
Range (min–max)	67–95	70–113
Android body type, No. (%)
Yes	5 (10.0)	10 (20.0)	χ²	1.961	0.161
No	45 (90.0)	40 (80.0)

BMI body mass index; people with BMI = 18.5–24.9 were considered to have normal weight and people with BMI = 25.0–29.9 were considered overweight (WHO, 2014), Android body type: Apple shape; No. number, SD standard deviation; P < 0.05: significant, P > 0.05: not significant